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A B S T R A C T
Background: There is a perception that the prevalence of anabolic-androgenic steroid (AAS) use is
increasing in the UK, with consequent individual and public health risks. Nevertheless, there is a lack of
real-time surveillance data to support the development of effective policy. This paper explores the
potential of Google Trends to complement existing surveillance methods by analysing user generated
search term data.
Methods: The Google Trends web tool was used to identify patterns of UK online interest in 15 AAS from
January 2011 to December 2015, with 10 ultimately suitable for further analysis. Time series analysis was
applied to the data.
Results: 10 steroids were ranked from most to least popular. All compounds had peaks in interest between
April to July, potentially indicating a consumer driven desire to attain a desired physique in time for
summer. Oral steroids were among the most searched for drugs which may have relevance for current
service provision to steroid users.
Conclusion: Alternative data sources such Google Trends may provide useful additional information to
supplement existing surveillance data. The limitations of this method however makes cautious
interpretation and triangulation with other data sources essential.
© 2017 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
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Anabolic-androgenic steroid (AAS) use, primarily by young men
intent on increasing muscularity, is thought to be rising in
prevalence (Evans-Brown, McVeigh, Perkins, & Bellis, 2012). This
non-medical use of AAS is associated with signiﬁcant cardiovas-
cular, endocrine, psychological and psychosocial morbidity (Nies-
chlag & Vorona, 2015a,b). AAS are frequently injected and users
now form the largest group using Needle and Syringe Programmes
(NSP) in the UK (Hope et al., 2016). The public health signiﬁcance of
AAS injecting becomes more signiﬁcant with the identiﬁcation of
rising rates of blood borne virus prevalence in this group (Hope
et al., 2016).
Despite the potential implications of AAS use both to the
individual and the larger population, there is an acknowledged lack
of real-time prevalence data (Antonopoulos & Hall, 2016). The best
available data come from the Crime Survey for England and Wales,
showing that in 2014/15 293,000 people used AAS in their lifetime* Corresponding author at: MRC/CSO SPHSU, 200 Renﬁeld Street, Glasgow, G2
3QB, United Kingdom.
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2015). The reliance of self-reporting of AAS use from a secretive
group, uncertainty among users about the consumed substances
and indeed what is deﬁned as AAS limits the usefulness of this data
(Home Ofﬁce, 2015). Increasing numbers of AAS users presenting
to NSP, alongside arrests, drug seizures, media reports, internet
forum monitoring and case reports provide a picture of increasing
prevalence (Evans-Brown et al., 2012). Nevertheless, current data
sources do not appear to provide a real-time indication of variation
in prevalence, potentially limiting the responsiveness of services
and public health policy.
The Internet has been identiﬁed as a key aspect for facilitating
AAS use (Brennan, Wells, & Van Hout, 2016), providing ready access
to supply (Cordaro, Lombardo, & Cosentino, 2011), information
(Andreasson & Johansson, 2015; Brennan et al., 2016) and
community (Andreasson & Johansson, 2015). Furthermore, it is
increasingly identiﬁed as a key driver for the dissemination of
media representations of physical ideals, with consistent evidence
associating social media usage with body dissatisfaction (Sassa-
telli, 2010).
Internet searches, for example through Google, are used to
access information and consumer products online These searches
provide data streams which can then be analysed through onlineicle under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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portal which allows users to analyse part of 3.5 billion daily Google
searches (Google, 2016). This internet tool provides data on
geographical and temporal patterns in user-speciﬁed search terms.
Epidemiologists are increasingly cognisant of the value of this data
to complement traditional sources, providing actionable intelli-
gence to policy-makers (Nuti et al., 2014). Examples of GT research
includes the tracking of ﬂu epidemics (Eysenbach, 2011), and the
use of drugs such as novel psychoactive substances (Deluca et al.,
2012) and synthetic cannabinoids (Curtis et al., 2015). The latter
two examples highlight the use of GT in situations where
traditional systems may be lacking and where the Internet plays
an important role in consumption. Consequently, this study is
intended to assess the feasibility of using GT to supplement what
we know about AAS related behaviour.
Methods
This study was approved by the University of Glasgow College of
Social Sciences ethics committee. Reference was made to Nuti
et al.’s (2014) guidelines for robust GT research. An important issue
in performing the analysis was to identify search terms which
corresponded closely with what was available for sale online.
Cordaro et al. (2011) identiﬁed 15 AAS compounds available for
sale through the internet. This research, while being 8 years old,
nevertheless corresponds with recent AAS user surveys of
commonly used compounds (Bates & McVeigh, 2016).
Where an AAS was known by a generic and brand name, the
term that produced the greater search volume was chosen. This
approach has its limitations; in particular as systematic variations
may exist depending on whether a generic or brand name was
used. Combining the searches was avoided in this study due to the
risk of double counting as the charts for generic and brand names
often produced similar time trends. When performing a GT query,
the user interface allows for the narrowing down of the scope of
the search to set categories such as business, health or sports. All
categories were allowed in the search as non-medical AAS use may
be viewed in different ways, for example as a health issue or part of
ﬁtness and beauty consumerism. The GT data were accessed and
downloaded on 14 January 2016. The time period selected was
from 1 January 2011 to 31 December 2015. This start date was
selected as the GT interface reported an improvement in geo-
locating data at this time. A signiﬁcant limitation of GT for research
is that Google maintains a high level of secrecy around their
algorithms (Eysenbach, 2011), and more details on this improve-
ment is unavailable. The GT searches were restricted to the UK as
this was the area of interest for this project. It is important to note
that a worldwide trend analysis would be difﬁcult to interpret, dueTable 1
Statistical tests for Google Trends data.
AAS Relative search volume Seasonality pres
on decompositi
More popular
Anavar 67 Y 
Trenbolone 52 Y 
Stanozolol 47 Y 
Dianabol 45 Y 
Sustanon 23 Y 
Less popular
Nandralone 11 Y 
Boldenone 9 Y 
Masteron 9 Y 
Metenolone 7 Y 
Testosterone enanthate 6 Y 
Signiﬁcance level taken at P < 0.0025 with Bonferroni correction.
p0.0025 (*) p0.0005 (**) p0.00005 (***).to differences in legislation and socio-cultural variations in AAS
use.
The individual AAS names were entered systematically into the
GT interface. This interface allows for a simultaneous comparison
of 5 search terms. The least popular search term was removed each
time such that the top ﬁve were identiﬁed. The process was
repeated in a second GT page and the next ﬁve, less popular search
terms were identiﬁed. This process was necessary as all data points
in each time series are normalised by GT such that they are relative
to the highest data point designated 100 (Google, 2016). The data
points produced represent the relative search volume (RSV),
deﬁned as the total number of searches for that term divided by the
total number of Google searches for the speciﬁed location and time
(Google, 2016). Of the 15 AAS identiﬁed by Cordaro et al. (2011),
10 provided sufﬁcient data to produce a time-trend chart. 5 of the
steroid compounds did not generate sufﬁcient data points for
comparative time-trend analysis. The data points were down-
loaded as .csv ﬁles for further analysis.
Statistical analysis
The R statistical package with the DeducerHansel Graphical
User Interface (GUI) package version 0.4 (Hacker, 2013) was used to
run multiplicative seasonal decomposition, which allowed for
visual inspection of the components of the time series. Visual
inspection was used to determine months of upward and
downward inﬂection for subsequent statistical tests. The Wilcoxon
signed-rank test was applied to determine if there were signiﬁcant
differences between search volumes in the peak (April-July) and
trough (September-December) months identiﬁed from the time
series decomposition. Both approaches are commonly used in
assessing seasonality in time series analysis (Nwogu, Iwueze &
Nlebedim, 2016). The Mann-Kendall test was used to detect overall
trends signiﬁcantly larger than the variance in the data for each
search term. We modiﬁed signiﬁcance points using the Bonferroni
correction to adjust for multiple testing. All p-values and tests are
reported.
Results
Table 1 lists the individual AAS ranked in order of popularity
based on RSV and the results of statistical testing. The individual
decomposition graphs for each AAS is available in the Supplemen-
tary material. Fig. 1 reproduces the GT output for the 5 more
popular AAS with the output for the less popular AAS in the
Supplementary material. A seasonal component for each AAS was
identiﬁed with peaks occurring in April to July and troughs from
September to December. This seasonality was statisticallyent
on
Wilcoxon signed
rank test (Sep-Dec/Apr-Jul)
Seasonal Mann Kendall Test
p < 0.0001** p < 0.0001** Tau = 0.628
p < 0.0001** p < 0.0001** Tau = 0.554
p < 0.0001** p < 0.0001** Tau = 0.778
P < 0.0001** P < 0.0001** Tau = 0.829
P < 0.0001** p < 0.0001** Tau = 0.907
p < 0.0001** p < 0.0001** Tau = 0.756
P < 0.000*** p = 0.254 Tau = 0.144
p < 0.0001** P < 0.002* Tau = 0.383
p < 0.001* p < 0.0001** Tau = 0.490
p = 0.015 p < 0.002* tau = 0.362
Fig. 1. Google Trends relative search volume for more popular AAS in the UK (Jan 2011-Dec 2015).
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tested with the Wilcoxon signed-rank test.
Statistically signiﬁcant trends were identiﬁed in all the AAS
except Boldenone. Anavar, Trenbolone, and Masteron had statisti-
cally signiﬁcant upward trends. Stanazolol, Dianabol, Sustanon,
Nandralone, Metenolone and Testosterone enanthate had statisti-
cally signiﬁcant downward trends.
Discussion
This study is the ﬁrst to apply time series analysis to GT data for
named AAS compounds in the UK. With Google having 86.7% of the
market share for internet searches, and over 50,000 searches a
second (Statista, 2016), the coverage provided by this study is
broad in comparison with UK based surveys. The standout ﬁnding
in this study is the presence of clear and consistent seasonal
variation with 9 of the 10 compounds reaching statistical
signiﬁcance. Peaks of search interest, noted from April to July,
may correspond to what Sassatelli (2010) describes as a ‘bulimic
seasonality’ in ﬁtness magazines, reﬂecting an interest in attaining
an attractive physique in time for summer. This observed
seasonality may support the notion of steroid use being part of
health and beauty consumerism (Brennan et al., 2016), as opposed
to being primarily related to body dysmorphia or a substance use
disorder. Health promotion and prevention messages, as well as
harm reduction services may be more effective if targeted during
these periods of increased internet search interest. Similar
recommendations have been made in response to seasonal spikes
in sexually transmitted infections (Cornelisse, Chow, Chen,
Bradshaw, & Fairley, 2015) with individuals preferring health
messages when they are at increased risk. It is important to note
however that harm reduction policies do not address the
underlying neoliberal and consumerism driven risk normalisation
underlying steroid use, which also needs to be addressed.
Our ﬁndings do need to be interpreted cautiously for a number
of reasons. Firstly, it is not possible to know the motivation behindthe Google searches. Compounds such as Trenbolone for example
are used as a veterinarian steroid, and a portion of search interest
may reﬂect this. It is notable however, that in the UK, Directive 96/
22/EC severely restricts veterinarian AAS use (EU Monitor, 2004).
Furthermore, with hundreds of thousands of websites focussing on
unsanctioned human use, (Brennan, Kanayama & Pope, 2013), it is
reasonable to believe that anabolic steroid web content is skewed
towards image and performance enhancement.
Searches may be performed by researchers, journalists and out
of curiosity and does not indicate intention to use or purchase.
Furthermore, it is possible that a Google search for one AAS
provides access to websites with information on the full range of
compounds, reducing the need for further searches. This study did
not use colloquial terms for various steroid products, rather names
derived from an earlier published study (Cordaro et al., 2011). It is
worth emphasising however that the use of colloquial terms
notwithstanding, steroid users are known to thoroughly research
their cycles (Andreasson & Johansson, 2015) and are likely to
require the precision that comes from scientiﬁc names when
performing web searches.
The lack of demographic data on who is performing the Google
searches limits the inferences we can make. Trends may also be
inﬂuenced by a number of confounding factors such as a general
web interest in other issues or incidental news stories creating a
spike in search interest in speciﬁc compounds. These limitations
have been identiﬁed in other GT work for example in the prediction
of inﬂuenza outbreaks (Eysenbach, 2011).
For the reasons above, interpretation of the ranking by RSV and
the upward and downward trends is problematic. Nevertheless, it
is notable that all the injectable steroids with the exception of
Primibolan are represented in both this study and a 2015 AAS
national survey (Bates & McVeigh, 2016), with Trenbolone being
particularly prominent. Trenbolone was traditionally considered
high risk and shunned by experienced bodybuilders in the 1980s
(Monaghan, 2001) and its rise in internet search popularity may
therefore warrant further investigation. Brennan et al. (2013)
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sites regarding its unsanctioned use, limited medical literature and
a presumed low risk of criminal conviction due to its veterinarian
legitimacy in some jurisdictions.
The large number of searches occurring for Dianabol and
Anavar may have signiﬁcance with regards to current health
service provision. These are both oral compounds, potentially more
hepatotoxic (Nieschlag & Vorona, 2015b), and may act as gateway
drugs to injectable steroids (Hildebrandt, Harty & Langenbucher,
2012). With the main focus of current UK services for steroid users
being NSPs (Hope et al., 2016), policy-makers may wish to evaluate
to what extent the needs of oral steroid users are being met. It is
worth noting that internet searches are far less likely to be met
with sanctioned harm reduction or health promotion messages
with such websites being substantially overwhelmed by pro-
steroid content (Brennan et al., 2013).
The presence of ﬂuctuating internet search volume of
individual compounds, in the context of a perceived rise in AAS
use overall, may be an area worth further investigation. While it is
not possible to draw conclusions on how search interest relates to
levels of use, time trend variation in levels of interest in different
AAS may gives some indication of what is occurring within the
wider AAS using community. More detailed web-analytics work on
internet vendor sites could link web searches to purchases (Curtis
et al., 2015). This is of particular interest if prospective users seem
to show greater interest in substances which are associated with
higher risks.
In conclusion, with current limited real-time, detailed AAS use
surveillance, alternative data sources such GT may provide useful
additional information. Cautious interpretation of GT data is
recommended and future work involving triangulation with other
data sources may make this method useful as a near real-time
barometer of AAS interest, and variations over time.
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